MedPath

Effectiveness of a Community Intervention in the Chronic Use of Benzodiazepines: (BENZOSTOPJUNTOS)

Not Applicable
Completed
Conditions
Inappropriate Prescribing
Interventions
Behavioral: Intervention for reducing benzodiazepines long-term use.
Registration Number
NCT06209827
Lead Sponsor
Andalusian Health Service
Brief Summary

This study aimed to assess the effectiveness of a comprehensive, multicomponent intervention utilizing education and support for Benzodiazepines withdrawal compared to standard care.

Detailed Description

The excessive use of benzodiazepines (BZDs) presents significant health concerns and high healthcare costs, particularly in Spain, where usage rates are among the highest globally. In Andalusian, over a 10% of the population use BZDs long-term, prompting the need for safe and effective reduction strategies.

This study aimed to assess the effectiveness of a comprehensive, multicomponent intervention utilizing education and support for BZD withdrawal compared to standard care.

The intervention involved educational discussions, consultations with health professionals, and letters supported by multiple scientific societies.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
472
Inclusion Criteria
  • users of health centre's with more than 4 weeks of benzodiazepines use.
  • users of health centre's over 18 years of age.
Exclusion Criteria
  • users of health centre's with mental disorder.
  • users of health centre's terminal.
  • users of health centre's with alcohol dependence.
  • users of health centre's with dementia.
  • users of health centre's who had intellectual disabilities.
  • users of health centre's unable to cooperate with the questionnaires.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention for reducing benzodiazepines long-term use.Intervention for reducing benzodiazepines long-term use.It included the multiple components as follows: (i) an exchange discussion with the patient describing the advantages, disadvantages and alternatives of benzodiazepines use and a tapering protocol with the support of educational material, (ii) the offer of a brief, if necessary, consultation with the family doctor, and (iii) a letter addressed to the patient supported by scientific societies.
Primary Outcome Measures
NameTimeMethod
Number of dispensing of benzodiazepines.3.5 years

Number of dispensing of benzodiazepines, measured at the level of the participant.

Secondary Outcome Measures
NameTimeMethod
Knowledge6 months

Knowledge: Empower questionary, measured at the level of the participant.

Life Quality6 months

Quality of life:Functional Status Measurement Sheets by coop World Organisation of Family Doctors (COOP/ WONCA):

The six COOP-WONCA Charts are described by vignettes and measured at the level of the participant: physical fitness, feelings, daily activities, social activities, change in health and overall health.

WONCA: World Organisation of Family Doctors

Trial Locations

Locations (1)

Ingrid Ferrer L贸pez

馃嚜馃嚫

Sevilla, Spain

漏 Copyright 2025. All Rights Reserved by MedPath